Shree Ganesh Biotech (India) Ltd. is a biotech firm, which engages in the production, processing, and marketing of hybrid seeds. The company is headquartered in Kolkata, West Bengal. The company went IPO on 2015-11-24. The firm is also involved in the business of tissue culture plants. The company is a provider of crop solutions to the farmer by supplying high yielding hybrid seeds and crop management, namely micronutrients and bioproducts. The firm is also engaged in research and development in the areas of superior breeding programs and biotechnology tools. The firm sells its products to the farmers in West Bengal, Odisha and Bihar.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.
11 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.